01:09PM, Tuesday 20 September 2016
A US pharmaceutical firm is set to create 100 jobs by setting up a new European office in Maidenhead.
Massachusetts-based Alnylam Pharmaceuticals announced today it is opening a new development and commercial hub in the town with space for 100 employees.
The firm is taking over offices at Braywick Gate, in Braywick Road, after a deal was agreed earlier in the summer.
The company specialises in RNAi therapeutics, a process which could 'silence' harmful genes.
Akshay Vaishnaw, executive vice president of R&D and chief medical officer at Alnylam, said: "We're thrilled to be expanding our global presence in the United Kingdom and Maidenhead in particular.
"This important new office will play a critical role in advancing our cutting-edge investigational RNAi therapies toward regulatory approval and launch in European markets to benefit patients with life-threatening diseases as quickly as possible."
Top Ten Articles
Wexham Park Hospital has urged members of the public to minimise pressures on services tomorrow by considering other treatment options before attending as the emergency department moves into the new assessment centre.